MoneyWorks4Me

Abbott India informs about statement of investor complaints

06 Apr 2017 Evaluate

Abbott India has informed about Statement of Investor Complaints under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the fourth quarter ended March 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..